Opendata, web and dolomites


Investigating the regulation of iron homeostasis by erythroferrone and therapeutic applications

Total Cost €


EC-Contrib. €






 INVESTIGERFE project word cloud

Explore the words cloud of the INVESTIGERFE project. It provides you a very rough idea of what is the project "INVESTIGERFE" about.

confirmed    erythroid    sought    thalassemias    iron    benefits    infections    biomedical    treatments    1950s    antagonization    cells    action    receptor    restricted    suppressed    manipulation    anemias    first    murine    independent    signaling    recovery    therapies    secondary    erythron    regulatory    disease    advantage    ineffective    leads    mouse    model    hepcidin    agonist    stores    examine    opened    therapy    regulator    regulators    envision    erfe    identification    contribution    cancer    release    overload    beta    intensifies    models    frequent    thalassemic    delineating    prerequisite    rheumatoid    mice    mechanism    triggered    treatment    red    human    erythroferrone    showed    search    tremendous    synthesis    levels    loading    disorders    blood    meet    inflammatory    anemia    chronic    thalassemia    assay    antagonist    arthritis    bowel    existence    hormone    homeostasis    proof    axes    abortus    pathologies    suppresses    absorption    kidney    molecules   

Project "INVESTIGERFE" data sheet

The following table provides information about the project.


Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 1˙499˙235 €
 EC max contribution 1˙499˙235 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-STG
 Funding Scheme ERC-STG
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2022-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

The existence of an “erythron-related regulator” that intensifies iron absorption and its release from stores to meet the requirements for red blood cells synthesis was proposed in the 1950s. Delineating this mechanism is of high biomedical importance as the pathway could be targeted to develop novel treatments for iron-restricted anemias that are very frequent but for which current therapies are ineffective (e.g. infections, inflammatory bowel disease, cancer, or chronic kidney disease) and for iron-loading anemias (e.g. thalassemias). We have recently identified the hormone erythroferrone (ERFE) and showed that it could be the long-sought erythroid regulator of iron homeostasis. ERFE suppresses the synthesis of the iron-regulatory hormone hepcidin to facilitate the recovery from anemia but leads to secondary iron overload in β-thalassemia. The potential of ERFE in the treatment of iron disorders is tremendous but understanding its mechanism of action is a prerequisite to envision ERFE-based therapies. The identification of ERFE has opened new research areas and our project will be organized around four axes. 1) Develop an assay to measure ERFE levels in human pathologies. Its contribution is not known and needs to be confirmed. 2) Identify the receptor for ERFE, the signaling pathways triggered by ERFE, and molecules with agonist/antagonist effects, a prerequisite in the development of new therapies. 3) Search for potential other erythroid regulators. We will take advantage of the Erfe-/- mice to determine whether hepcidin could be suppressed by an ERFE-independent mechanism. 4) Study the potential of ERFE manipulation in therapy in the mouse. We will first establish a proof of principle in a mouse model of anemia (B. abortus). The benefits of ERFE antagonization will be addressed in thalassemic mice. We will also examine the role of ERFE in murine models of chronic anemia: chronic kidney disease, inflammatory bowel disease, rheumatoid arthritis and infections.


year authors and title journal last update
List of publications.
2019 Sabrina Bondu, Anne-Sophie Alary, Carine Lefèvre, Alexandre Houy, Grace Jung, Thibaud Lefebvre, David Rombaut, Ismael Boussaid, Abderrahmane Bousta, François Guillonneau, Prunelle Perrier, Samar Alsafadi, Michel Wassef, Raphaël Margueron, Alice Rousseau, Nathalie Droin, Nicolas Cagnard, Sophie Kaltenbach, Susann Winter, Anne-Sophie Kubasch, Didier Bouscary, Valeria Santini, Andrea Toma, Mathild
A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome
published pages: eaav5467, ISSN: 1946-6234, DOI: 10.1126/scitranslmed.aav5467
Science Translational Medicine 11/500 2020-01-30
2019 Irene Artuso, Mariateresa Pettinato, Antonella Nai, Alessia Pagani, Ugo Sardo, Benjamin Billoré, Maria Rosa Lidonnici, Cavan Bennett, Giacomo Mandelli, Sant-Rayn Pasricha, Giuliana Ferrari, Clara Camaschella, Léon Kautz, Laura Silvestri
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice
published pages: e87-e90, ISSN: 0390-6078, DOI: 10.3324/haematol.2018.199810
Haematologica 104/3 2020-01-30

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INVESTIGERFE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INVESTIGERFE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)


The Enemy of the Good: Towards a Theory of Moral Progress

Read More  

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More  

SuperH (2019)

Discovery and Characterization of Hydrogen-Based High-Temperature Superconductors

Read More